Delivery Order SPE2DE24DA010-SPE2D625F2SQ0

Award Date 6/16/25
Potential Completion Date 6/20/25
Potential Value $7.9K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
This federal contract award, valued at $24,350.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The award is a fixed-price delivery order contract for the delivery of cardiovascular medical devices and related services, such as electrophysiology catheters, heart valve prosthetics, surgical implants, cardiac mapping systems, and neuromodulation devices. The contract has an ultimate completion...
This federal contract award, valued at $21,425.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices and equipment. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of May 21, 2025. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been a critical supplier of advanced cardiovascular medical technologies to federal agencies, particularly...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for fixed-price cardiovascular medical devices with economic price adjustment, with a completion date of March 18, 2025. The award was made under an Indefinite Delivery Contract (IDC), likely an existing Blanket Purchase Agreement (BPA) between Abbott Laboratories and the Department of...
This is a federal contract award to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, by the Defense Logistics Agency (DLA) for the delivery of cardiovascular medical devices and related services. The contract is a Delivery Order with a fixed price and economic price adjustment, valued at $25,715.85, with a completion date of April 1, 2025. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a large,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices and diagnostics. The contract, valued at $2,822.00, is a fixed-price delivery order with economic price adjustment. It does not have a set-aside designation, indicating full and open competition. The contract requires Abbott Laboratories Inc., through its Abbott Vascular Inc. division, to provide a range of cardiovascular medical...
This federal contract award, valued at $8,000.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large medical device manufacturer, through its Abbott Vascular Inc. division. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, cardiac monitors, and surgical implants. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and...
This federal contract award, valued at $26,275.85, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer. The contract is a fixed-price delivery order with an economic price adjustment clause, tasking Abbott Vascular Inc., a division of Abbott Laboratories, to provide a range of cardiovascular medical devices and related services to federal healthcare systems, particularly the...
This federal contract award, valued at $1,262.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a multinational pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract is a fixed-price delivery order with economic price adjustment, with a period of performance ending on March 27, 2025. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a key supplier of advanced...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F2SQ0
    Delivery Order

This federal contract award to Abbott Laboratories Inc., a global healthcare company, was issued by the Defense Logistics Agency (DLA) for the delivery of cardiovascular medical devices and related services. The $7,941.84 fixed-price contract with economic price adjustment has a completion date of June 20, 2025. Abbott Laboratories, through its Abbott Vascular Inc. division, has established itself as a critical supplier of advanced cardiovascular technologies to federal healthcare systems, including the Department of Veterans Affairs (VA) and DLA. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, underscoring its strategic importance in federal healthcare procurement, such as a $117,140,796 IDC with DLA for cardiovascular technology "procedural packages" and a $1,408,950 IDV with the VA's Veterans Integrated Service Network 19 for medical product consignment.

Generated 9/15/25, 9:42 AM